Trial Profile
A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Feb 2024
Price :
$35
*
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Cancer; Diabetic nephropathies; Haematological malignancies; Malignant melanoma; Non-alcoholic steatohepatitis; Pancreatic cancer; Solid tumours; Viral hepatitis
- Focus Pharmacokinetics
- Sponsors Biogen
- 30 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2011 New trial record